Botulinum Toxin Market is Projected to Soar at a Value CAGR of 7.6% from 2018 to 2026
Transparency Market Research (TMR) has published a new report titled, "Botulinum Toxin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026". According to the report, the global botulinum toxin market was valued at US$ 4,527.0 Mn in 2017 and is projected to reach US$ 8,718.7 Mn by 2026, expanding at a CAGR of 7.6% during the forecast period. Global increase in prevalence of spasticity and cervical dystonia and rise in the incidence rate of glabellar lines, crow’s foot, and facial wrinkles are driving the botulinum toxin market. Furthermore, continuously growing worldwide geriatric population and adoption of non-surgical aesthetic and therapeutics procedures are boosting the botulinum toxin market. North America is expected to dominate the global botulinum toxin market during the forecast period owing to the increasing awareness regarding noninvasive or minimally invasive, non-surgical aesthetic and therapeutics procedures. The market in Europe is projected to be a lucrative market for botulinum toxin due to the increasing demand for botulinum toxin procedures in the region. The market in Asia Pacific is expected to expand at a rapid pace owing to the increase in geriatric population and favorable government regulations regarding botulinum toxin procedures. The market in the region is projected to expand at a significant CAGR of 8.7% during the forecast period.
Browse Press Release @
https://www.transparencymarketresearch.com/pressrelease/botulinum-toxin-market.htm
Increase in prevalence of aesthetic problems and therapeutic diseases to drive the global botulinum toxin market
Increase in the prevalence of spasticity & cervical dystonia and rise in the incidences of glabellar lines and facial wrinkles are key factors driving the global botulinum toxin market. According to American Association of Neurological Surgeons, globally, spasticity affects more than 12 million people worldwide. In the U.S., around 400,000 people are affected with some degree of spasticity related to cerebral palsy. According to Brain Foundation, in the U.S., rate of cervical dystonia is around 30 in 100,000 population. Prevalence of spasticity and cervical dystonia is increasing year-over-year, thereby increasing the demand for non-surgical therapeutics procedures, which in turn is driving the market. Consistent rise in the geriatric population worldwide is a major factor boosting the global botulinum toxin market. According to the United Nations, in 2017, the global geriatric population was 962 million, comprising around 13% of the global population and is expected to reach 2.1 billion in 2050. Surge in awareness regarding botulinum toxin procedure is fuelling the market.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26132
Botulinum toxin type A to be highly lucrative segment
The botulinum toxin type A segment dominates the global botulinum toxin market. It is projected to account for 82% share of the market by 2026, expanding at a CAGR of 7.5 % during the forecast period. The segment is anticipated to reach a market value of US$ 7,153.5 Mn by 2026. Botulinum toxin type A is widely utilized in the treatment of cervical dystonia, spasticity, glabellar lines, and crow’s foot.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26132
Adoption of non-surgical aesthetic and therapeutics procedures to boost the botulinum toxin market
In terms of application, the global botulinum toxin market has been segmented into aesthetic and therapeutics. Therapeutics is the leading segment of the market, and was valued at US$ 2,623.4 Mn in 2017. The segment is expected to reach a market value of US$ 4,819.4 Mn by 2026, expanding at a CAGR of 7.0% during the forecast period. Studies suggest that prevalence of glabellar lines, lateral canthal lines, crow’s foot, and facial wrinkles is common among the geriatric population, worldwide; thus increasing geriatric population is expected to propel the market during the forecast period.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com